1.   Amid a string of drug recalls and some patient deaths, Wood has called for the drug agency to be more aggressive in monitoring medicines on the market.

2.   Drug recalls are highly unusual.

3.   Industry insiders say the slowdown may be in response to several high-profile drug recalls in recent years.

4.   Its pharmaceutical business has been reeling from a major drug recall, a plant shutdown and disappointments in drug research.

5.   As drug recalls have made headlines in recent years, Congress has begun to pay closer attention to whether the FDA is doing its job properly.